BRASILIA/RIO DE JANEIRO, (Reuters) - Brazilian health regulator Anvisa yesterday approved emergency use of COVID-19 vaccines from China’s Sinovac Biotech Ltd and Britain’s AstraZeneca, clearing the way for immunizations as the pandemic enters a deadly second wave.
The article Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin appeared first on Stabroek News.